Search

1202760
1201004
1195994
393884
209802
Paediatrics Icon Emeritus Professor Maurice Kibel passes away
We mourn the passing away of Emeritus Professor Maurice Kibel , who was associated with SATVI since its establishment in 2001. Professor Kibel was an icon and pioneer in paediatrics in South Africa, establishing the Child Health Unit in the...
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.

News

Wednesday, 1 March 2017

Dr Michele Tameris, SATVI Investigator has been awarded accreditation as an Established Researcher by the National Research Foundation, having recently been rated in the category C1, in acknowledgement of national and international standing.

Publication Date:
Monday, February 27, 2017 - 19:45

SATVI authors Professor Mark Hatherill, Associate Professor Tom Scriba and Dr Munyaradzi Musvosvi have co-authored a paper titled "The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes" appearing in the Tuberculosis Journal.

Publication Date:
Monday, February 27, 2017 - 16:30

UCT Health Sciences Faculty recently said farewell to Professor Greg Hussey, founding Director of SATVI, (Director: Vaccines for Africa and Interim Director of the HSF 2015-2016) upon his retirement.

Publication Date:
Sunday, February 5, 2017 - 21:00

SATVI author, Associate Professor Tom Scriba has co-authored a paper titled "Safety and Immunogenicity of Adenovirus 35 TB Vaccine Candidate in Adults with Active or Previous TB: a Randomized Trial" appearing in the American Journal of Respiratory and Critical Care Medicine.

Publication Date:
Tuesday, January 17, 2017 - 08:00

Pages